Erratum: Improved activities of CREB binding protein, heterogeneous nuclear ribonucleoproteins and proteasome following downregulation of noncoding hsrv transcripts help suppress Poly(Q) pathogenesis in fly models (Genetics 184 (927–945) DOI: 10.1534/genetics.109.113696);Improved activities of CREB binding protein, heterogeneous nuclear ribonucleoproteins and proteasome following downregulation of noncoding hsrω transcripts help suppress poly(Q) pathogenesis in fly models

Genetics

Volumn 184, Issue 4, 2010, Pages 927-945

  Mallik, Moushami ^a   Lakhotia, Subhash C ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; DROSOPHILA INHIBITOR OF APOPTOSIS PROTEIN 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; PROTEASOME; REGULATOR PROTEIN; RNA; UNCLASSIFIED DRUG; DROSOPHILA PROTEIN; HRB87F PROTEIN, DROSOPHILA; NUCLEAR PROTEIN; PEPTIDE; POLYGLUTAMINE; UBIQUITIN; UNTRANSLATED RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; EYE INJURY; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; ANIMAL; CHEMISTRY; DOWN REGULATION; DROSOPHILA MELANOGASTER; EYE DISEASE; GENETICS; HUMAN; MALE; METABOLISM; MUTATION; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; TRANSCRIPTION INITIATION;

ANIMALS; CREB-BINDING PROTEIN; DOWN-REGULATION; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EYE DISEASES; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; MALE; MUTATION; NUCLEAR PROTEINS; PEPTIDES; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; RNA, UNTRANSLATED; TRANSCRIPTIONAL ACTIVATION; UBIQUITIN;

EID: 77955858671     PISSN: 00166731     EISSN: 00166731     Source Type: Journal    
DOI: 10.1534/genetics.119.302466     Document Type: Erratum

References (79)

1. ANDERSON, J., R. BHANDARI and J. P. KUMAR, 2005 A genetic screen identifies putative targets and binding partners of CREB-binding protein in the developing Drosophila eye. Genetics 171: 1655-1672.
2. ARRASATE, M., S. MITRA, E. S. SCHWEITZER, M. R. SEGAL and S. FINKBEINER, 2004 Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431: 805-810.
3. ARYA, R., and S. C. LAKHOTIA, 2006 A simple nail polish imprint technique for examination of external morphology of Drosophila eyes. Curr. Sci. 90: 1179-1180.
4. ARYA, R., M. MALLIK and S. C. LAKHOTIA, 2007 Heat shock genes: integrating cell survival and death. J. Biosci. 32: 595-610.
5. BAE, B. I., H. XU, S. IGARASHI, M. FUJIMURO, N. AGRAWAL et al., 2005 p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease. Neuron 47: 29-41.
6. BELOTE, J. M., and E. FORTIER, 2002 Targeted expression of dominant negative proteasome mutants in Drosophila melanogaster. Genesis 34: 80-82.
7. BENNETT, E. J., N. F. BENCE, R. JAYAKUMAR and R. R. KOPITO, 2005 Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol. Cell 17: 351-365.
8. BERKE, S. J., F. A. SCHMIED, E. R. BRUNT, L. M. ELLERBY and H. L. PAULSON, 2004 Caspase-mediated proteolysis of the polyglutamine disease protein ataxin-3. J. Neurochem. 89: 908-918.
9. BONINI, N. M., and M. E. FORTINI, 2003 Human neurodegenerative diseasemodeling using Drosophila. Annu. Rev. Neurosci. 26: 627-656.
10. BRANCO, J., I. AL-RAMAHI, L. UKANI, A. M. PEREZ, P. FERNANDEZ-FUNEZ et al., 2008 Comparative analysis of geneticmodifiers in Drosophila points to common and distinct mechanisms of pathogenesis among polyglutamine diseases. Hum. Mol. Genet. 17: 376-390.
11. CARLSON, K. M., J. M. ANDRESEN and H. T. ORR, 2009 Emerging pathogenic pathways in the spinocerebellar ataxias. Curr. Opin. Genet. Dev. 19: 247-253.
12. CHAI, Y., S. L. KOPPENHAFER, S. J. SHOESMITH, M. K. PEREZ and H. L. PAULSON, 1999 Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. Hum. Mol. Genet. 8: 673-682.
13. CHAN, H. Y., and N. M. BONINI, 2000 Drosophila models of human neurodegenerative disease. Cell Death Differ. 7: 1075-1080.
14. CHAN, H. Y., J. M. WARRICK, G. L. GRAY-BOARD, H. L. PAULSON and N. M. BONINI, 2000 Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9: 2811-2820.
15. CHAN, H. Y., J. M. WARRICK, I. ANDRIOLA, D. MERRY and N. M. BONINI, 2002 Genetic modulation of polyglutamine toxicity by protein conjugation pathways in Drosophila. Hum. Mol. Genet. 11: 2895-2904.
16. CHEN, S., V. BERTHELIER, W. YANG and R. WETZEL, 2001 Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity. J. Mol. Biol. 311: 173-182.
17. CHEN, S., F. A. FERRONE and R. WETZEL, 2002 Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation. Proc. Natl. Acad. Sci. USA 99: 11884-11889.
18. CUMMINGS, C. J., M. A. MANCINI, B. ANTALFFY, D. B. DEFRANCO, H. T. ORR et al., 1998 Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet. 19: 148-154.
19. CUMMINGS, C. J., Y. SUN, P. OPAL, B. ANTALFFY, R. MESTRIL et al., 2001 Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10: 1511-1518.
20. DANTUMA, N. P., K. LINDSTEN, R. GLAS, M. JELLNE and M. G. MASUCCI, 2000 Short-lived green fluorescent proteins for quantifying ubiquitin/proteasome- dependent proteolysis in living cells. Nat. Biotechnol. 18: 538-543.
21. DAVIES, S. W., M. TURMAINE, B. A. COZENS, M. DIFIGLIA, A. H. SHARP et al., 1997 Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90: 537-548.
22. DIAZ-HERNANDEZ, M., A. G. VALERA, M. A. MORAN, P. GOMEZ-RAMOS, B. ALVAREZ-CASTELAO et al., 2006 Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain. J. Neurochem. 98: 1585-1596.
23. DIFIGLIA, M., E. SAPP, K. O. CHASE, S. W. DAVIES, G. P. BATES et al., 1997 Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277: 1990-1993.
24. DUNAH, A. W., H. JEONG, A. GRIFFIN, Y. M. KIM, D. G. STANDAERT et al., 2002 Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science 296: 2238-2243.
25. EKENGREN, S., Y. TRYSELIUS, M. S. DUSHAY, G. LIU, H. STEINER et al., 2001 A humoral stress response in Drosophila. Curr. Biol. 11: 714-718.
26. ELLERBY, L. M., R. L. ANDRUSIAK, C. L. WELLINGTON, A. S. HACKAM, S. S. PROPP et al., 1999 Cleavage of atrophin-1 at caspase site aspartic acid 109 modulates cytotoxicity. J. Biol. Chem. 274: 8730-8736.
27. EVERETT, C. M., and N. W. WOOD, 2004 Trinucleotide repeats and neurodegenerative disease. Brain 127: 2385-2405.
28. EVERT, B. O., U. WULLNER and T. KLOCKGETHER, 2000 Cell death in polyglutamine diseases. Cell Tissue Res. 301: 189-204.
29. GATCHEL, J. R., and H. Y. ZOGHBI, 2005 Diseases of unstable repeat expansion: mechanisms and common principles. Nat. Rev. Genet. 6: 743-755.
30. GOLDBERG, Y. P., D. W. NICHOLSON, D. M. RASPER, M. A. KALCHMAN, H. B. KOIDE et al., 1996 Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nat. Genet. 13: 442-449.
31. GUSELLA, J. F., and M. E. MACDONALD, 2000 Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat. Rev. Neurosci. 1: 109-115.
32. HAY, B. A., 2000 Understanding IAP function and regulation: a view from Drosophila. Cell Death Differ. 7: 1045-1056.
33. HAY, B. A., T. WOLFF and G. M. RUBIN, 1994 Expression of baculovirus P35 prevents cell death in Drosophila. Development 120: 2121-2129.
34. HAYNES, S. R., D. JOHNSON, G. RAYCHAUDHURI and A. L. BEYER, 1991 The Drosophila Hrb87F gene encodes a new member of the A and B hnRNP protein group. Nucleic Acids Res. 19: 25-31.
35. HELMLINGER, D., L. TORA and D. DEVYS, 2006 Transcriptional alterations and chromatin remodeling in polyglutamine diseases. Trends Genet. 22: 562-570.
36. IIJIMA-ANDO, K., P. WU, E. A. DRIER, K. IIJIMA and J. C. YIN, 2005 cAMP-response element-binding protein and heat-shock protein 70 additively suppress polyglutamine-mediated toxicity in Drosophila. Proc. Natl. Acad. Sci. USA 102: 10261-10266.
37. JI, Y., and A. V. TULIN, 2009 Poly(ADP-ribosyl)ation of heterogeneous nuclear ribonucleoproteins modulates splicing. Nucleic Acids Res. 37: 3501-3513.
38. JIANG, H., F. C. NUCIFORA, JR., C. A. ROSS and D. B. DEFRANCO, 2003 Cell death triggered by polyglutamine-expanded huntingtin in a neuronal cell line is associated with degradation of CREB-binding protein. Hum. Mol. Genet. 12: 1-12.
39. JOLLY, C., and S. C. LAKHOTIA, 2006 Human sat III and Drosophila hsr omega transcripts: a common paradigm for regulation of nuclear RNA processing in stressed cells. Nucleic Acids Res. 34: 5508-5514.
40. KLEMENT, I. A., P. J. SKINNER, M. D. KAYTOR, H. YI, S. M. HERSCH et al., 1998 Ataxin-1 nuclear localization and aggregation: role in polyglutamine- induced disease in SCA1 transgenic mice. Cell 95: 41-53.
41. KUMAR, J. P., T. JAMAL, A. DOETSCH, F. R. TURNER and J. B. DUFFY, 2004 CREB binding protein functions during successive stages of eye development in Drosophila. Genetics 168: 877-893.
42. LAKHOTIA, S. C., 2003 The noncoding developmentally active and stress inducible hsrω gene of Drosophila melanogaster integrates post-transcriptional processing of other nuclear transcripts, pp. 203-221 in Noncoding RNAs: Molecular Biology and Molecular Medicine, edited by J. BARCISZEWSKI and V. A. ERDMANN. Kluwer Academic/Plenum Publishers, New York.
43. LAKHOTIA, S. C., P. RAY, T. K. RAJENDRA and K. V. PRASANTH, 1999 The non-coding transcripts of hsr-omega gene in Drosophila: Do they regulate trafficking and availability of nuclear RNA-processing factors? Curr. Sci. 77: 553-563.
44. LI, S. H., and X. J. LI, 2004 Huntingtin-protein interactions and the pathogenesis of Huntington's disease. Trends Genet. 20: 146-154.
45. LI, S. H., A. L. CHENG, H. ZHOU, S. LAM, M. RAO et al., 2002 Interaction of Huntington disease protein with transcriptional activator Sp1. Mol. Cell. Biol. 22: 1277-1287.
46. LILJA, T., D. QI, M. STABELL and M. MANNERVIK, 2003 The CBP coactivator functions both upstream and downstream of Dpp/Screw signaling in the early Drosophila embryo. Dev. Biol. 262: 294-302.
47. LUDLAM, W. H., M. H. TAYLOR, K. G. TANNER, J. M. DENU, R. H. GOODMAN et al., 2002 The acetyltransferase activity of CBP is required for wingless activation and H4 acetylation in Drosophila melanogaster. Mol. Cell. Biol. 22: 3832-3841.
48. MALLIK, M., and S. C. LAKHOTIA, 2009a RNAi for the large noncoding hsromega transcripts suppresses polyglutamine pathogenesis in Drosophila models. RNA Biol. 6: 464-478.
49. MALLIK, M., and S. C. LAKHOTIA, 2009b The developmentally active and stress-inducible noncoding hsr{omega} gene is a novel regulator of apoptosis in Drosophila. Genetics 183: 831-852.
50. MERIENNE, K., D. HELMLINGER, G. R. PERKIN, D. DEVYS and Y. TROTTIER, 2003 Polyglutamine expansion induces a protein-damaging stress connecting heat shock protein 70 to the JNK pathway. J. Biol. Chem. 278: 16957-16967.
51. MORFINI, G., G. PIGINO, G. SZEBENYI, Y. YOU, S. POLLEMA et al., 2006 JNK mediates pathogenic effects of polyglutamine-expanded androgen receptor on fast axonal transport. Nat. Neurosci. 9: 907-916.
52. NELSON, B., S. NISHIMURA, H. KANUKA, E. KURANAGA, M. INOUE et al., 2005 Isolation of gene sets affected specifically by polyglutamine expression: implication of the TOR signaling pathway in neurodegeneration. Cell Death Differ. 12: 1115-1123.
53. NUCIFORA, JR., F. C., M. SASAKI, M. F. PETERS, H. HUANG, J. K. COOPER et al., 2001 Interference by huntingtin and atrophin-1 with cbp-mediated transcription leading to cellular toxicity. Science 291: 2423-2428.
54. ONA, V. O., M. LI, J. P. VONSATTEL, L. J. ANDREWS, S. Q. KHAN et al., 1999 Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature 399: 263-267.
55. PRASANTH, K. V., T. K. RAJENDRA, A. K. LAL and S. C. LAKHOTIA, 2000 Omega speckles: a novel class of nuclear speckles containing hnRNPs associated with noncoding hsr-omega RNA in Drosophila. J. Cell Sci. 113: 3485-3497.
56. RORTH, P., 1996 A modular misexpression screen in Drosophila detecting tissue-specific phenotypes. Proc. Natl. Acad. Sci. USA 93: 12418-12422.
57. ROUAUX, C., J. P. LOEFFLER and A. L. BOUTILLIER, 2004 Targeting CREB-binding protein (CBP) loss of function as a therapeutic strategy in neurological disorders. Biochem. Pharmacol. 68: 1157-1164.
58. SAHA, R. N., and K. PAHAN, 2006 HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 13: 539-550.
59. SANCHEZ, I., C. J. XU, P. JUO, A. KAKIZAKA, J. BLENIS et al., 1999 Caspase-8 is required for cell death induced by expanded polyglutamine repeats. Neuron 22: 623-633.
60. SAUDOU, F., S. FINKBEINER, D. DEVYS and M. E. GREENBERG, 1998 Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95: 55-66.
61. SAUMWEBER, H., P. SYMMONS, R. KABISCH, H. WILL and F. BONHOEFFER, 1980 Monoclonal antibodies against chromosomal proteins of Drosophila melanogaster: establishment of antibody producing cell lines and partial characterization of corresponding antigens. Chromosoma 80: 253-275.
62. SCAPPINI, E., T. W. KOH, N. P. MARTIN and J. P. O'BRYAN, 2007 Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase. Hum. Mol. Genet. 16: 1862-1871.
63. SCHAFFAR, G., P. BREUER, R. BOTEVA, C. BEHRENDS, N. TZVETKOV et al., 2004 Cellular toxicity of polyglutamine expansion proteins: mechanism of transcription factor deactivation. Mol. Cell 15: 95-105.
64. SCHWEISGUTH, F., 1999 Dominant-negative mutation in the beta2 and beta6 proteasome subunit genes affect alternative cell fate decisions in the Drosophila sense organ lineage. Proc. Natl. Acad. Sci. USA 96: 11382-11386.
65. SENGUPTA, S., and S. C. LAKHOTIA, 2006 Altered expressions of the noncoding hsromega gene enhances poly-Q-induced neurotoxicity in Drosophila. RNA Biol. 3: 28-35.
66. SHAO, J., and M. I. DIAMOND, 2007 Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum. Mol. Genet. 16(Spec. No. 2): R115-R123.
67. SOFOLA, O. A., P. JIN, Y. QIN, R. DUAN, H. LIU et al., 2007 RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a Drosophila model of FXTAS. Neuron 55: 565-571.
68. STEFFAN, J. S., L. BODAI, J. PALLOS, M. POELMAN, A. MCCAMPBELL et al., 2001 Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413: 739-743.
69. TAYLOR, J. P., A. A. TAYE, C. CAMPBELL, P. KAZEMI-ESFARJANI, K. H. FISCHBECK et al., 2003 Aberrant histone acetylation, altered transcription, and retinal degeneration in a Drosophila model of polyglutamine disease are rescued by CREB-binding protein. Genes Dev. 17: 1463-1468.
70. VENKATRAMAN, P., R. WETZEL, M. TANAKA, N. NUKINA and A. L. GOLDBERG, 2004 Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol. Cell 14: 95-104.
71. WAELTER, S., A. BOEDDRICH, R. LURZ, E. SCHERZINGER, G. LUEDER et al., 2001 Accumulation of mutant huntingtin fragments in aggresome-like inclusion bodies as a result of insufficient protein degradation. Mol. Biol. Cell 12: 1393-1407.
72. WANG, J., C. E. WANG, A. ORR, S. TYDLACKA, S. H. LI et al., 2008 Impaired ubiquitin-proteasome system activity in the synapses of Huntington's disease mice. J. Cell Biol. 180: 1177-1189.
73. WARRICK, J. M., H. L. PAULSON, G. L. GRAY-BOARD, Q. T. BUI, K. H. FISCHBECK et al., 1998 Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila. Cell 93: 939-949.
74. WARRICK, J. M., H. Y. CHAN, G. L. GRAY-BOARD, Y. CHAI, H. L. PAULSON et al., 1999 Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70. Nat. Genet. 23: 425-428.
75. WELLINGTON, C. L., L. M. ELLERBY, A. S. HACKAM, R. L. MARGOLIS, M. A. TRIFIRO et al., 1998 Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the polyglutamine tract. J. Biol. Chem. 273: 9158-9167.
76. WELLINGTON, C. L., L. M. ELLERBY, C. A. GUTEKUNST, D. ROGERS, S. WARBY et al., 2002 Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease. J. Neurosci. 22: 7862-7872.
77. YANG, W., J. R. DUNLAP, R. B. ANDREWS and R. WETZEL, 2002 Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells. Hum. Mol. Genet. 11: 2905-2917.
78. YOO, S. Y., M. E. PENNESI, E. J. WEEBER, B. XU, R. ATKINSON et al., 2003 SCA7 knockin mice model human SCA7 and reveal gradual accumulation of mutant ataxin-7 in neurons and abnormalities in short-term plasticity. Neuron 37: 383-401.
79. ZU, K., M. L. SIKES, S. R. HAYNES and A. L. BEYER, 1996 Altered levels of the Drosophila HRB87F/hrp36 hnRNP protein have limited effects on alternative splicing in vivo. Mol. Biol. Cell 7: 1059-1073.